ArticleScientific reports2026
Differentiation of psychotic and affective disorder patients from healthy controls using the niacin skin flush test: a novel analytical method and the SKINREMS system-preliminary research.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
According to the phospholipid membrane theory of psychotic disorders, fatty acid metabolism may play a role in the etiopathogenesis of schizophrenia (SCH) and related disorders. Weakened skin reactions to niacin have been documented in SCH and bipolar disorder (BD), prompting research into biomarkers underlying these responses. So far, there is also no standard for performing and interpreting the niacin skin flush test (NSFT) which creates an opportunity for development in this area. The NSFT was conducted based on the SKINREMS system and an original method of analyzing measurements. 120 individuals including 33 patients diagnosed with first-episode psychosis (FEP), 22 with BD, 13 with schizoaffective disorder (SA), 13 with chronic schizophrenia (CS), and 39 healthy controls (HC) participated in the study. NSFT differentiated patients from HC and among subgroups of patients based on color saturation, specific time points, and niacin solution concentrations. The NSFT is a fast, effective, and cheap method that allows the differentiation of individuals suffering from psychotic disorders from HC. Standardization of the test method may contribute to more precise searches for biomarkers responsible of responses in the NSFT and can support the diagnostic process. The presented study is preliminary and exploratory in nature. Developing a method of using NSFT may contribute to a more precise search for biomarkers responsible for the results and thus to the diagnostic process.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.